Arcellx, Inc. (ACLX)
66.27
+1.96
(+3.05%)
USD |
NASDAQ |
Jan 09, 16:00
66.26
-0.02
(-0.02%)
After-Hours: 20:00
Arcellx Research and Development Expense (Annual): 157.09M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Gilead Sciences, Inc. | 5.816B |
| Johnson & Johnson | 17.26B |
| Amicus Therapeutics, Inc. | 109.36M |
| Relmada Therapeutics, Inc. | 46.18M |
| Invivyd, Inc. | 137.25M |